An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK.
Robert MalcolmCiara BuckleyJudith ShoreAngela StainthorpeBelen MartiAndrea WhiteJens DeckertMatteo VerniaJoão L CarapinhaAna López-MarcoNicolas NikolaidisOlaf WendlerPublished in: Expert review of pharmacoeconomics & outcomes research (2023)
The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.